Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways

European Journal of Pharmacology

Volumn 674, Issue 2-3, 2012, Pages 188-199

  Baek, Yi Yong ^a,b   Cho, Dong Hui ^a,b   Choe, Jongseon ^a   Lee, Hansoo ^b   Jeoung, Dooil ^b   Ha, Kwon Soo ^a,b   Won, Moo Ho ^a   Kwon, Young Guen ^c   Kim, Young Myeong ^a,b  

^a Kangwon National University College of Medicine   (South Korea)

^b Kangwon National University   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Akt; Angiogenesis; Cell cycle; ERK; Taurine

Indexed keywords

BETA ALANINE; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; TAURINE; TAURINE TRANSPORTER;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIUM;

CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; EXTRACELLULAR SPACE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TAURINE; VASCULAR DISEASES;

EID: 84855527767     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.11.022     Document Type: Article

References (40)

1. Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., Isner, J.M., 1998. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97, 1114-1123. (Pubitemid 28152883)
2. Bhavsar, T.M., Patel, S.N., Lau-Cam, C.A., 2010. Protective action of taurine, given as a pretreatment or as a posttreatment, against endotoxin-induced acute lung inflammation in hamsters. J. Biomed. Sci. 17 (Suppl 1), S19.
3. Bussolino, F., Mantovani, A., Persico, G., 1997. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22, 251-256. (Pubitemid 27310945)
4. Casey, R.G., Gang, C., Joyce, M., Bouchier-Hayes, D.J., 2007. Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J. Vasc. Res. 44, 31-39. (Pubitemid 46115950)
5. Chesney, R.W., Lippincott, S., Gusowski, N., Padilla, M., Zelikovic, I., 1986. Studies on renal adaptation to altered dietary amino acid intake: tissue taurine responses in nursing and adult rats. J. Nutr. 116, 1965-1976. (Pubitemid 18020062)
6. Choi, D., Kim, S.J., Kwon, do.Y., Lee, S.Y., Kim, Y.C., 2009. Taurine depletion by beta-alanine inhibits induction of hepatotoxicity inmice treated acutelywith carbon tetrachloride. Adv. Exp. Med. Biol. 643, 305-311.
7. Chytil, A., Waltner-Law, M., West, R., Friedman, D., Aakre, M., Barker, D., Law, B., 2004. Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes. J. Biol. Chem. 279, 47688-47698. (Pubitemid 39540915)
8. Dawson Jr., R., Liu, S., Jung, B., Messina, S., Eppler, B., 2000. Effects of high salt diets and taurine on the development of hypertension in the stroke-prone spontaneously hypertensive rat. Amino Acids 19, 643-665.
9. Favot, L., Keravis, T., Lugnier, C., 2004. Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4. Thromb. Haemost. 92, 634-645. (Pubitemid 39248022)
10. Fennessy, F.M., Moneley, D.S., Wang, J.H., Kelly, C.J., Bouchier-Hayes, D.J., 2003. Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation 107, 410-415. (Pubitemid 36158042)
11. Gavard, J., Gutkind, J.S., 2006. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8, 1223-1234. (Pubitemid 44660587)
12. Ghosh, J., Das, J., Manna, P., Sil, P.C., 2009. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-κB, p38 and JNK MAPK pathway. Toxicol. Appl. Pharmacol. 240, 73-87.
13. Ho, P.Y., Hsu, S.P., Liang, Y.C., Kuo, M.L., Ho, Y.S., Lee, W.S., 2008. Inhibition of the ERK phosphorylation plays a role in terbinafine-induced p21 up-regulation and DNA synthesis inhibition in human vascular endothelial cells. Toxicol. Appl. Pharmacol. 229, 86-93.
14. Ideishi, M., Miura, S., Sakai, T., Sasaguri, M., Misumi, Y., Arakawa, K., 1994. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. J. Hypertens. 12, 653-661.
15. Izumi, M., Yokoi, M., Nishikawa, N.S., Miyazawa, H., Sugino, A., Yamagishi, M., Yamaguchi, M., Matsukage, A., Yatagai, F., Hanaoka, F., 2000. Transcription of the catalytic 180-kDa subunit gene of mouse DNA polymerase alpha is controlled by E2F, an Ets-related transcription factor, and Sp1. Biochim. Biophys. Acta 24, 341-352. (Pubitemid 30427345)
16. Jirmanova, L., Afanassieff, M., Gobert-Gosse, S., Markossian, S., Savatier, P., 2002. Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 21, 5515-5528. (Pubitemid 34983541)
17. Jones, D.P., Miller, L.A., Chesney, R.W., 1995. The relative roles of external taurine concentration and medium osmolality in the regulation of taurine transport in LLC-PK1 and MDCK cells. Pediatr. Res. 37, 227-232.
18. Kim, I., Moon, S.O., Kim, S.H., Kim, H.J., Koh, Y.S., Koh, G.Y., 2001. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB activation in endothelial cells. J. Biol. Chem. 276, 7614-7620.
19. Kim, C.K., Choi, Y.K., Lee, H., Ha, K.S., Won, M.H., Kwon, Y.G., Kim, Y.M., 2010. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways. Mol. Pharmacol. 78, 142-150.
20. Lavoie, J.N., L'Allemain, G., Brunet, A., Müller, R., Pouysségur, J., 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608-20616. (Pubitemid 26281839)
21. Lee, S.J., Namkoong, S., Kim, Y.M., Kim, C.K., Lee, H., Ha, K.S., Chung, H.T., Kwon, Y.G., Kim, Y.M., 2006. Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. Am. J. Physiol. Heart Circ. Physiol. 291, 2836-2846.
22. Liu, G., Lozano, G., 2005. p21 stability: linking chaperones to a cell cycle checkpoint. Cancer Cell 7, 113-114. (Pubitemid 40248335)
23. Midwinter, R.G., Peskin, A.V., Vissers, M.C., Winterbourn, C.C., 2004. Extracellular oxidation by taurine chloramine activates ERK via the epidermal growth factor receptor. J. Biol. Chem. 279, 32205-32211. (Pubitemid 39014668)
24. Motley, E.D., Eguchi, K., Patterson, M.M., Palmer, P.D., Suzuki, H., Eguchi, S., 2007. Mechanism of endothelial nitric oxide synthase phosphorylation and activation by thrombin. Hypertension 49, 577-583.
25. Muise-Helmericks, R.C., Grimes, H.L., Bellacosa, A., Malstrom, S.E., Tsichlis, P.N., Rosen, N., 1998. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 273, 29864-29872. (Pubitemid 28510001)
26. Murakami, S., Nara, Y., Yamori, Y., 1996. Taurine accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats. Life Sci. 58, 1643-1651. (Pubitemid 26145145)
27. Nurse, P., 2001. Ordering S phase and M phase in the cell cycle. Cell 105, 297-306.
28. Oshima, Y., Yajima, S., Yamazaki, K., Matsushita, K., Tagawa, M., Shimada, H., 2010. Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinoma. Ann. Thorac. Cardiovasc. Surg. 16, 389-393.
29. Pyun, B.J., Choi, S., Lee, Y., Kim, T.W., Min, J.K., Kim, Y., Kim, B.D., Kim, J.H., Kim, T.Y., Kim, Y.M., Kwon, Y.G., 2008. Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Cancer Res. 68, 227-235. (Pubitemid 351380124)
30. Qiu, W., Leibowitz, B., Zhang, L., Yu, J., 2010. Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene 29, 1622-1632.
31. Roberts, J.M., Koff, A., Polyak, K., Firpo, E., Collins, S., Ohtsubo, M., 1994. Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harb. Symp. Quant. Biol. 59, 31-38.
32. Satoh, H., Kang, J., 2009. Modulation by taurine of human arterial stiffness and wave reflection. Adv. Exp. Med. Biol. 643, 47-55.
33. Satoh, H., Sperelakis, N., 1998. Review of someactions of taurine on ion channels of cardiac muscle cells and others. Gen. Pharmacol. 30, 451-463. (Pubitemid 28106957)
34. Sherr, C.J., Roberts, J.M., 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
35. Sherr, C.J., Roberts, J.M., 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512. (Pubitemid 29297917)
36. Terauchi, A., Nakazaw, A., Johkura, K., Yan, L., Usuda, N., 1998. Immunohistochemical localization of taurine in various tissues of the mouse. Amino Acids 15, 151-160. (Pubitemid 28444643)
37. Tomi, M., Terayama, T., Isobe, T., Egami, F., Morito, A., Kurachi, M., Ohtsuki, S., Kang, Y.S., Terasaki, T., Hosoya, K., 2007. Function and regulation of taurine transport at the inner blood-retinal barrier. Microvasc. Res. 73, 100-106. (Pubitemid 46241230)
38. Wang, J.H., Redmond, H.P., Watson, R.W., Condron, C., Bouchier-Hayes, D., 1996. The beneficial effect of taurine on the prevention of human endothelial cell death. Shock 6, 331-338. (Pubitemid 126727111)
39. Weinberg, R.A., 1995. The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
40. Wu, Q.D., Wang, J.H., Fennessy, F., Redmond, H.P., Bouchier-Hayes, D., 1999. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am. J. Physiol. 277, 1229-1238.